| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Published online before print June 7, 2007
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||









From the Interdepartmental Program in Vascular Biology and Transplantation,
Boyer Center for Molecular Medicine, and the Departments of Pathology
and Biomedical Engineering,* Yale University School of Medicine, New Haven, Connecticut
Macrophages that are recruited to the site of implanted biomaterials undergo fusion to form surface-damaging foreign body giant cells. Exposure of peripheral blood monocytes to interleukin-4 can recapitulate the fusion process in vitro. In this study, we used interleukin-4 to induce multinucleation of murine bone marrow-derived macrophages and observed changes in cell shape, including elongation and lamellipodia formation, before fusion. Because cytoskeletal rearrangements are regulated by small GTPases, we examined the effects of inhibitors of Rho kinase (Y-32885) and Rac activation (NSC23766) on fusion. Y-32885 did not prevent cytoskeletal changes or fusion but limited the extent of multinucleation. NSC23766, on the other hand, inhibited lamellipodia formation and fusion in a dose-dependent manner. In addition, we found that in control cells, these changes were preceded by Rac1 activation. However, NSC23766 did not block the uptake of polystyrene microspheres. Likewise, short interfering RNA knockdown of Rac1 limited fusion without limiting phagocytosis. Thus, phagocytosis and fusion can be partially decoupled based on their susceptibility to NSC23766. Furthermore, poly(ethylene-co-vinyl acetate) scaffolds containing NSC23766 attenuated foreign body giant cell formation in vivo. These observations suggest that targeting Rac1 activation could protect biomaterials without compromising the ability of macrophages to perform beneficial phagocytic functions at implantation sites.
This article has been cited by other articles:
![]() |
A. Cerezo, M. C. Guadamillas, J. G. Goetz, S. Sanchez-Perales, E. Klein, R. K. Assoian, and M. A. del Pozo The Absence of Caveolin-1 Increases Proliferation and Anchorage- Independent Growth by a Rac-Dependent, Erk-Independent Mechanism Mol. Cell. Biol., September 15, 2009; 29(18): 5046 - 5059. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. MacLauchlan, E. A. Skokos, N. Meznarich, D. H. Zhu, S. Raoof, J. M. Shipley, R. M. Senior, P. Bornstein, and T. R. Kyriakides Macrophage fusion, giant cell formation, and the foreign body response require matrix metalloproteinase 9 J. Leukoc. Biol., April 1, 2009; 85(4): 617 - 626. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Helming, J. Winter, and S. Gordon The scavenger receptor CD36 plays a role in cytokine-induced macrophage fusion J. Cell Sci., February 15, 2009; 122(4): 453 - 459. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Helming, E. Tomasello, T. R. Kyriakides, F. O. Martinez, T. Takai, S. Gordon, and E. Vivier Essential Role of DAP12 Signaling in Macrophage Programming into a Fusion-Competent State Sci. Signal., October 28, 2008; 1(43): ra11 - ra11. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Moreno, I. Mikhailenko, M. M. Tondravi, and A. D. Keegan IL-4 promotes the formation of multinucleated giant cells from macrophage precursors by a STAT6-dependent, homotypic mechanism: contribution of E-cadherin J. Leukoc. Biol., December 1, 2007; 82(6): 1542 - 1553. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |